ROYCE & ASSOCIATES LP - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 96 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2014. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2014$708,000
-34.4%
268,0000.0%0.00%
-33.3%
Q2 2014$1,080,000
-28.8%
268,000
-19.0%
0.00%
-25.0%
Q1 2014$1,516,000
-4.5%
331,000
-9.6%
0.00%
-20.0%
Q4 2013$1,588,000
-30.2%
366,000
-36.5%
0.01%
-28.6%
Q3 2013$2,275,000
+64.1%
576,000
-12.7%
0.01%
+75.0%
Q2 2013$1,386,000660,0000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2014
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders